Sequences

Sample result

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

GLP-1, a diabetes hormone

Protein → Patent proteins · Automatic (Smith-Waterman)

Download as Excel

Every list and the search record, one sheet each.

Query
GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
Set
Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
5,000 sequences, 3,061 publications, 1,851 families

Charts

Identity against coverage

5,000 hits by identity and query coverage. 5,000 with a date.

Has a date707075758080858590909595100100Identity (%)Query coverage (%)
Show table
Hits by identity
BandHas a dateAll
100%553553
95 to 99.9%992992
90 to 94.9%2,6382,638
80 to 89.9%814814
70 to 79.9%33
Hits by query coverage
BandHas a dateAll
100%3,6063,606
95 to 99.9%876876
90 to 94.9%483483
80 to 89.9%3535

Hits by year

1,851 families by year of first publication, 1990 to 2026.

Has a dateFamilies0501001502001990199319961999200220052008201120142017202020232026
Show table
Families by year of first publication
YearHas a dateAll
199022
199222
199311
199411
199511
199633
199722
199822
19991111
20001313
20011919
20023434
20032626
20043131
20054444
20065050
20075959
20086060
20097878
20105757
20117272
20127474
20137777
20146969
20158181
20167676
20178282
20187979
20197777
20208787
2021106106
20228585
20239191
20249191
2025151151
20265757

Where hits align on the query

The top 20 hits on GLP-1, a query of 31 amino acids: 20 cover the whole query, none differs from it.

Aligned partDiffers from the queryGLP-1 · 31 amino acids151015202531HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGAAA55132.1A31422.1AAB11984.1DI506186DI527435AAB11995.1AAE02614.1DI540976DI521338DI502216DJ789879DI520483AAE49428.1AAE49430.1AAE49429.1AAE49432.1DI501808AAY78103.1BD613525BD613528
Show table
The top 20 hits on GLP-1, positions on the query
HitQuery fromQuery toIdentityDiffers atGaps atX at
AAA55132.1131100.0%NoneNoneNone
A31422.1131100.0%NoneNoneNone
AAB11984.1131100.0%NoneNoneNone
DI506186131100.0%NoneNoneNone
DI527435131100.0%NoneNoneNone
AAB11995.1131100.0%NoneNoneNone
AAE02614.1131100.0%NoneNoneNone
DI540976131100.0%NoneNoneNone
DI521338131100.0%NoneNoneNone
DI502216131100.0%NoneNoneNone
DJ789879131100.0%NoneNoneNone
DI520483131100.0%NoneNoneNone
AAE49428.1131100.0%NoneNoneNone
AAE49430.1131100.0%NoneNoneNone
AAE49429.1131100.0%NoneNoneNone
AAE49432.1131100.0%NoneNoneNone
DI501808131100.0%NoneNoneNone
AAY78103.1131100.0%NoneNoneNone
BD613525131100.0%NoneNoneNone
BD613528131100.0%NoneNoneNone

Patents 3.1K

Columns
Tick the columns each row shows, then choose Show. The arrows move a column.

3,061 publications in 1,851 families match these filters.

  1. WO 9001540-A1990-02-22

    METHOD FOR STABILIZING HETEROLOGOUS PROTEIN EXPRESSION AND VECTORS FOR USE THEREIN

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 75 to 105. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    75 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 105
    

    31 of 31 identical, no gaps.

  2. WO 9011296-A11990-10-04

    INSULINOTROPIC HORMONE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

  3. Method for Producing Cysteine-Free Peptides

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  4. JP 1993304976-A1993-11-19

    PRODUCTION OF PEPTIDE

    TAKEDA CHEM IND LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  5. GLUCAGON-LIKE PEPTIDE AND INSULINOTROPIN DERIVATIVES

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  6. US 5512459-A1996-04-30

    Enzymatic method for modification or recombinant polypeptides

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  7. US 5707826-A1998-01-13

    Enzymatic method for modification of recombinant polypeptides

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  8. US 5861284-A1999-01-19

    Method for producing a biologically active recombinant cysteine-free parathyroid hormone (1-34)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 2 to 32. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    2 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 32
    

    31 of 31 identical, no gaps.

  9. WO 1999038984-A1999-08-05

    Process for producing peptide with the use of accessory peptide

    SUNTORY LTD,KAZUHIRO OSUE,MASAYUKI YABUTA,YUJI SUZUKI

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 124 to 154. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit   124 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 154
    

    31 of 31 identical, no gaps.

  10. Process for production of peptide using supplementary peptide

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 124 to 154. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit   124 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 154
    

    31 of 31 identical, no gaps.

  11. JP 1999310597-A1999-11-09

    Novel peptide compound as analogue of glucagon-like peptide-1 (7-37), process for producing the same, and preparation composition containing the same

    ADIR ET CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  12. GLUCAGON-LIKE PEPTIDE-1 CRYSTALS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  13. US 6110707-A2000-08-29

    Recombinant expression of proteins from secretory cell lines

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

  14. WO 2000052193-A2000-09-08

    Method for regulating cleavage by OmpT protease

    SUNTORY LTD,KAZUAKI OKUNO,MASAYUKI YABUTA,KAZUHIRO OSUE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 154 to 184. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit   154 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 184
    

    31 of 31 identical, no gaps.

  15. METHOD FOR CONTROLLING CLEAVAGE BY OmpT PROTEASE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 154 to 184. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit   154 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 184
    

    31 of 31 identical, no gaps.

  16. WO 0066138-A22000-11-09

    Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue

    BIONEBRASKA, INC. (US)

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  17. WO 0066142-A22000-11-09

    Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain

    BIONEBRASKA, INC. (US)

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  18. WO 0069900-A22000-11-23

    Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components

    Conjuchem, Inc. (CA)

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  19. WO 0069911-A12000-11-23

    Long lasting insulinotropic peptides

    Conjuchem, Inc. (CA)

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  20. WO 0077039-A22000-12-21

    Glp-1 as a diagnostic test to determine _g(b)-cell function and the presence of the condition of igt and type-ii diabetes

    BIONEBRASKA, INC. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  21. WO 0104156-A12001-01-18

    Peptides that lower blood glucose levels

    Zealand Pharmaceuticals A/S (DK)

    Query Match 100.0%Identity 100.0%Family of 6

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 6

    Grouped by a shared priority claim, EP 99610043.4.

  22. JP 2001501593-A2001-02-06

    Methods for regulating gastrointestinal motility

    AMYLIN PHARMACEUTICALS INC

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  23. US 6191102-A2001-02-20

    Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  24. WO 0136643-A12001-05-25

    Nucleic acid construct for optimized production of products

    TRANSKARYOTIC THERAPIES, INC. (US)

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  25. ANALOGUES OF GLP-1

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  26. JP 2001158749-A2001-06-12

    Sustained release of peptide

    SCIOS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  27. WO 0155213-A22001-08-02

    Process for solubilizing glucagon-like peptide 1 compounds

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%Family of 6

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 6

    Grouped by the same title and applicant. No priority claim is on record.

  28. US 6287806-A2001-09-11

    Method for producing a biologically active recombinant cysteine-free peptide

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 2 to 32. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    2 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 32
    

    31 of 31 identical, no gaps.

  29. WO 0187322-A22001-11-22

    Peptide pharmaceutical formulations

    BIONEBRASKA, INC. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  30. WO 0189554-A22001-11-29

    Treatment of acute coronary syndrome with glp-1

    BIONEBRASKA, INC. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  31. WO 0198331-A22001-12-27

    Glucagon-like peptide-1 analogs

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  32. US 6344180-A2002-02-05

    GLP-1 as a diagnostic test to determine .beta.-cell function and the presence of the condition of IGT and type II diabetes

    BioNebraska, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  33. WO 0210195-A22002-02-07

    Modified peptides with increased potency

    THERATECHNOLOGIES INC. (CA)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  34. JP 2002507188-A2002-03-05

    Use of glucagon-like peptide-1 (GLP-1) or analogs to abolish catabolic changes after surgery

    ELI LILLY & CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  35. JP 2002508332-A2002-03-19

    Glucagon-like peptide-1 crystals

    ELI LILLY AND CO

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  36. JP 2002512175-A2002-04-23

    Derivatives of GLP-1 analogues

    NOVO NORDISK AS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  37. WO 0234285-A22002-05-02

    Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide

    Restoragen, Inc. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  38. US 6403361-A2002-06-11

    Enzymatic method for modification of recombinant polypeptides

    Restoragen, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  39. WO 0246227-A22002-06-13

    Glp-1 fusion proteins

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  40. WO 0247715-A22002-06-20

    Compositions of peptide crystals

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  41. WO 0248192-A22002-06-20

    Amidated glucagon-like peptide-1

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  42. JP 2002522068-A2002-07-23

    Differentiation of non-insulin-producing cells into insulin-producing cells by GLP-1 or Exendin-4, and utilization thereof

    THE GOVERNMENT OF THE UNITED STATES NATIONAL INSTITUTE OF BIOLOGICAL STANDARDS AND CONTROL UNITED KINGDOM SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 60/095917.

  43. Process for Solubilizing Glucagon-Like Peptide 1 Compounds

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  44. JP 2002526454-A2002-08-20

    Use of GLP-1 or analogs in treatment of stroke

    ELI LILLY AND CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  45. EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 (7-36) ON ANTRO-PYLORO-DUODENAL MOTILITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  46. JP 2002531578-A2002-09-24

    Analogues of GLP-1

    SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES SAS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  47. JP 2002533115-A2002-10-08

    PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules

    THE GENERAL HOSPITAL CORP

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  48. JP 2002538081-A2002-11-12

    GLP-1 analogues

    SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES SAS, THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  49. TREATMENT OF ACUTE CORONARY SYNDROME WITH GLP-1

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  50. GLUCAGON-LIKE PEPTIDE-1 ANALOGS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.